Alejandro Paolini
General Manager
Siemens Healthineers Mesoamerica
/
View from the Top

Demographic Changes Impact Tech Development

By Alessa Flores | Tue, 07/30/2019 - 10:49

Q: How is Siemens Healthineers shaping the future of the medical imaging and diagnostics segments in Mexico?
A: We are convinced that innovation and technology are the keys to optimizing global healthcare systems and fully improving care for all people. For more than a century, Siemens Healthineers has pushed the boundaries of medical technology with a broad solutions portfolio. Our digital technologies enable healthcare providers to increase the value of their journey while expanding precision medicine, thus transforming care delivery and improving patient experience. We are working closely with different players from the healthcare sector to find new opportunities and introduce new business models that can improve the quality of healthcare in Mexico.
We are also introducing new technologies to the country: our ACUSON Sequoia ultrasound and our Biomatrix MRI. ACUSON Sequoia is a remarkably fast, fully focused B-mode imaging system with no degradation of near-field or far-field resolution. Biomatrix, on the other hand, is an innovative and exclusive technology that automatically adapts to the patient’s anatomical and physiological characteristics. Biomatrix’s sensors capture respiratory and head motions, boosting consistency in the images and helping the user to select the optimal exam strategy. This combination ensures high-quality results.
Q: What are the challenges and opportunities in the market given the goals of the federal administration to increase healthcare services?
A: It is very important to focus on improving healthcare in the country. Mexico invests around 6 percent of its GPD in healthcare, while developed countries invest 9 percent or more. There is much to be improved — infrastructure, hospitals, equipment and systems — so Mexicans can access quality healthcare. There is also a great need to increase private investment in healthcare, otherwise, the gap will not be filled. The increasing aging and growing population, as well as the prevalence of chronic-degenerative diseases are making healthcare a priority worldwide. Mexico should not be an exception. Besides innovation, we need to create new partnerships and business models that offer clinical, operational and financial advantages for our customers.
Q: How will Siemens Healthineers’ ACUSON Sequoia change diagnostic practices in Mexico?
A: Mexico has the second-highest OECD obesity incidence among adults at 33 percent of the total population. However, this problem does not only affect Mexico but more than 600 million people around the world. Imaging patients with different sizes and characteristics is normally a challenge. Siemens Healthineers designed the new ACUSON Sequoia to adapt to the bioacoustics variations of each patient, including tissue density, stiffness and absorption. This platform has unique features that allow up to 40cm of penetration with high-resolution images, reducing the need to repeat scans, unclear diagnoses and contributing to more confident results.
Q: How is digitalization changing healthcare practices and how can it be implemented in Mexico’s fractured system?
A: Digitalization in the healthcare sector is already a reality. AI, Big Data and healthcare analytics have improved operations and management of laboratories and hospitals and have benefited the patient, allowing faster and more accurate diagnostics with more personalized and less invasive treatments.
In Mexico, we can use digitalization to improve the patient experience, prioritizing complex cases that require more attention and avoiding unnecessary interventions. For example, data analytics can be implemented to prevent diseases and to determine the patient pathway. It is possible to use digitalization to increase efficiency, productivity and improve healthcare processes. Information is the main engine for AI and in Mexico we have a lot of it. Unfortunately, much of it is fragmented. It is vital to integrate and standardize this data if we want to develop a national AI policy.

Alessa Flores Alessa Flores Senior Journalist and Industry Analyst